Rankings
▼
Calendar
ARVN Q1 2024 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena
ARVN
Arvinas, Inc.
$907M
Q1 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$25M
-22.2% YoY
Gross Profit
$24M
93.3% margin
Operating Income
-$83M
-329.2% margin
Net Income
-$69M
-274.3% margin
EPS (Diluted)
$-0.97
QoQ Revenue Growth
+158.7%
Cash Flow
Operating Cash Flow
-$98M
Free Cash Flow
-$98M
Stock-Based Comp.
$19M
Balance Sheet
Total Assets
$1.2B
Total Liabilities
$603M
Stockholders' Equity
$610M
Cash & Equivalents
$88M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$25M
$33M
-22.2%
Gross Profit
$24M
$31M
-23.4%
Operating Income
-$83M
-$88M
+5.0%
Net Income
-$69M
-$82M
+15.3%
← FY 2024
All Quarters
Q2 2024 →